U.S. Circulating Tumor Cells Market Size, Share & Trends Analysis Report By Application (Clinical/Liquid Biopsy, Research), By Specimen (Bone Marrow, Blood), By Product, By Technology, And Segment Forecasts, 2024 - 2030

Market Segmentation

• U.S. Circulating Tumor Cells Technology Outlook (Revenue in USD Million, 2018 - 2030)
  • CTC detection & enrichment methods
    • Immunocapture (label-based)
      • Positive selection
      • Negative selection
    • Size-based separation (label-free)
      • Membrane-based
      • Microfluidic-based
    • Density-based separation (label-free)
    • Combined methods
  • CTC Direct Detection Methods
    • SERS
    • Microscopy
    • Others
  • CTC Analysis
• U.S. Circulating Tumor Cells Application Outlook (Revenue in USD Million, 2018 - 2030)
  • Clinical/ Liquid Biopsy
    • Risk Assessment
    • Screening and Monitoring
  • Research
    • Cancer stem cell & tumorogenesis research
    • Drug/therapy development
• U.S. Circulating Tumor Cells Product Outlook (Revenue in USD Million; 2018 - 2030)
  • Kits & Reagents
  • Blood Collection Tubes
  • Devices or Systems
• U.S. Circulating Tumor Cells Specimen Outlook (Revenue in USD Million; 2018 - 2030)
  • Blood
  • Bone Marrow
  • Other Body Fluids

Report content

Qualitative Analysis

• Industry overview
• Industry trends
• Market drivers and restraints
• Market size
• Growth prospects
• Porter’s analysis
• PESTEL analysis
• Key market opportunities prioritized
• Competitive landscape
  • Company overview
  • Financial performance
  • Product benchmarking
  • Latest strategic developments

Quantitative Analysis

• Market size, estimates, and forecast from 2018 to 2030
• Market estimates and forecast for product segments up to 2030
• Country market size and forecast for product segments up to 2030
• Market estimates and forecast for application segments up to 2030
• Country market size and forecast for application segments up to 2030
• Company financial performance